Details
Stereochemistry | MIXED |
Molecular Formula | C22H32N2O6.H2O4S |
Molecular Weight | 518.578 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.OC(CNCCCCCCNCC(O)C1=CC(O)=C(O)C=C1)C2=CC=C(O)C(O)=C2
InChI
InChIKey=GTDCHGNGVGRHQY-UHFFFAOYSA-N
InChI=1S/C22H32N2O6.H2O4S/c25-17-7-5-15(11-19(17)27)21(29)13-23-9-3-1-2-4-10-24-14-22(30)16-6-8-18(26)20(28)12-16;1-5(2,3)4/h5-8,11-12,21-30H,1-4,9-10,13-14H2;(H2,1,2,3,4)
Molecular Formula | C22H32N2O6 |
Molecular Weight | 420.4993 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | H2O4S |
Molecular Weight | 98.078 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/195789Curator's Comment: description was created based on several sources, including, http://home.intekom.com/pharm/intramed/ipradinf.html
Sources: http://www.ncbi.nlm.nih.gov/pubmed/195789
Curator's Comment: description was created based on several sources, including, http://home.intekom.com/pharm/intramed/ipradinf.html
Hexoprenaline is a selective beta2-adrenoreceptor agonist indicated for use in the treatment of bronchospasm associated with obstructive airways diseases, including asthma, bronchitis and emphysema. In many countries the drug is used as tocolytic agent (under the trade name gynipral).
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL210 Sources: http://www.ncbi.nlm.nih.gov/pubmed/195789 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://www.ncbi.nlm.nih.gov/pubmed/195789 |
Palliative | Unknown Approved UseUnknown |
||
Primary | Unknown Approved UseUnknown |
|||
Sources: http://www.ncbi.nlm.nih.gov/pubmed/195789 |
Primary | Unknown Approved UseUnknown |
||
Preventing | GYNIPRAL Approved UseGynipral prevents threatened abortion with premature labour. |
PubMed
Title | Date | PubMed |
---|---|---|
Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma. | 1977 Jul |
|
[Tocolysis with hexoprenalin and salbutamol in a clinical comparison]. | 1983 Mar |
|
A comparison of the relative toxicities of beta-sympathomimetic tocolytic agents. | 1985 Oct |
|
Flow injection potentiometric assay of hexoprenaline in its pure state, pharmaceutical preparations, and biological samples. | 2008 |
|
Treatment of pregnant women with a betamimetic and verapamil increases the micronuclei frequency in umbilical cord blood lymphocytes. | 2008 Aug |
|
Management of foetal asphyxia by intrauterine foetal resuscitation. | 2010 Sep |
Sample Use Guides
Hexoprenaline can be given by metered aerosol in doses of 200 to 400μg, up to 5 times daily (in asthma), or as an infusion of 0,30 ug and 0,45 ug per minute or as 1-2 tablets q.i.d (0.5 mg per tablet) (maintenance dose in premature labour).
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:34:07 GMT 2023
by
admin
on
Fri Dec 15 15:34:07 GMT 2023
|
Record UNII |
U851S9102C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
FF-75
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
258331
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | RxNorm | ||
|
250-974-8
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
C83756
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL1589896
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
292266
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
m6013
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
U851S9102C
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
32266-10-7
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
36094
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
100000086703
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
SUB02516MIG
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
DBSALT001080
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY | |||
|
DTXSID6046688
Created by
admin on Fri Dec 15 15:34:07 GMT 2023 , Edited by admin on Fri Dec 15 15:34:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |